Literature DB >> 21965670

The C-terminal αI domain linker as a critical structural element in the conformational activation of αI integrins.

Gabriele Weitz-Schmidt1, Thomas Schürpf, Timothy A Springer.   

Abstract

The activation of α/β heterodimeric integrins is the result of highly coordinated rearrangements within both subunits. The molecular interactions between the two subunits, however, remain to be characterized. In this study, we use the integrin α(L)β(2) to investigate the functional role of the C-linker polypeptide that connects the C-terminal end of the inserted (I) domain with the β-propeller domain on the α subunit and is located at the interface with the βI domain of the β chain. We demonstrate that shortening of the C-linker by eight or more amino acids results in constitutively active α(L)β(2) in which the αI domain is no longer responsive to the regulation by the βI domain. Despite this intersubunit uncoupling, both I domains remain individually sensitive to intrasubunit conformational changes induced by allosteric modulators. Interestingly, the length and not the sequence of the C-linker appears to be critical for its functionality in α/β intersubunit communication. Using two monoclonal antibodies (R7.1 and CBR LFA-1/1) we further demonstrate that shortening of the C-linker results in the gradual loss of combinational epitopes that require both the αI and β-propeller domains for full reactivity. Taken together, our findings highlight the role of the C-linker as a spring-like element that allows relaxation of the αI domain in the resting state and controlled tension of the αI domain during activation, exerted by the β chain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965670      PMCID: PMC3234956          DOI: 10.1074/jbc.M111.282830

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Structural and functional studies with antibodies to the integrin beta 2 subunit. A model for the I-like domain.

Authors:  C Huang; Q Zang; J Takagi; T A Springer
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  Locking in alternate conformations of the integrin alphaLbeta2 I domain with disulfide bonds reveals functional relationships among integrin domains.

Authors:  C Lu; M Shimaoka; Q Zang; J Takagi; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2.

Authors:  Xing Chen; Can Xie; Noritaka Nishida; Zongli Li; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  Modulation of integrin activation by an entropic spring in the {beta}-knee.

Authors:  Benoit J Smagghe; Po-Ssu Huang; Yih-En Andrew Ban; David Baker; Timothy A Springer
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

5.  Structure of an integrin with an alphaI domain, complement receptor type 4.

Authors:  Can Xie; Jianghai Zhu; Xing Chen; Lizhi Mi; Noritaka Nishida; Timothy A Springer
Journal:  EMBO J       Date:  2009-12-24       Impact factor: 11.598

6.  Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation.

Authors:  C Lu; M Ferzly; J Takagi; T A Springer
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

7.  NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.

Authors:  J R Huth; E T Olejniczak; R Mendoza; H Liang; E A Harris; M L Lupher; A E Wilson; S W Fesik; D E Staunton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

8.  Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesion.

Authors:  T A Kelly; D D Jeanfavre; D W McNeil; J R Woska; P L Reilly; E A Mainolfi; K M Kishimoto; G H Nabozny; R Zinter; B J Bormann; R Rothlein
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

9.  An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond.

Authors:  C Lu; M Shimaoka; M Ferzly; C Oxvig; J Takagi; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

10.  Folding and function of I domain-deleted Mac-1 and lymphocyte function-associated antigen-1.

Authors:  P Yalamanchili; C Lu; C Oxvig; T A Springer
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

View more
  8 in total

1.  Identification, characterization, and epitope mapping of human monoclonal antibody J19 that specifically recognizes activated integrin α4β7.

Authors:  JunPeng Qi; Kun Zhang; Qiao Zhang; Yi Sun; Ting Fu; GuoHui Li; JianFeng Chen
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

2.  Leukocyte integrin αLβ2 headpiece structures: The αI domain, the pocket for the internal ligand, and concerted movements of its loops.

Authors:  Mehmet Sen; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-02       Impact factor: 11.205

3.  Mechanically Regulated Outside-In Activation of an I-Domain-Containing Integrin.

Authors:  Debin Mao; Shouqin Lü; Xiao Zhang; Mian Long
Journal:  Biophys J       Date:  2020-08-05       Impact factor: 4.033

4.  Anti-αLβ2 antibodies reveal novel endocytotic cross-modulatory functionality.

Authors:  Riccardo V Mancuso; Jens Casper; Albrecht G Schmidt; Stephan Krähenbühl; Gabriele Weitz-Schmidt
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

5.  Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1.

Authors:  Mehmet Sen; Adem C Koksal; Koichi Yuki; Jianchuan Wang; Timothy A Springer
Journal:  J Biol Chem       Date:  2018-03-05       Impact factor: 5.157

6.  A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood.

Authors:  Karl Welzenbach; Riccardo V Mancuso; Stephan Krähenbühl; Gabriele Weitz-Schmidt
Journal:  Br J Pharmacol       Date:  2015-10-19       Impact factor: 8.739

7.  An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2.

Authors:  Mehmet Sen; Koichi Yuki; Timothy A Springer
Journal:  J Cell Biol       Date:  2013-11-25       Impact factor: 10.539

Review 8.  Action and Traction: Cytoskeletal Control of Receptor Triggering at the Immunological Synapse.

Authors:  William A Comrie; Janis K Burkhardt
Journal:  Front Immunol       Date:  2016-03-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.